Literature DB >> 20185819

TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor.

Pradeep Bista1, Weike Zeng, Sarah Ryan, Veronique Bailly, Jeffrey L Browning, Matvey E Lukashev.   

Abstract

Components of lymphotoxin beta receptor (LTBR)-associated signaling complexes, including TRAF2, TRAF3, NIK, IKK1, and IKK2 have been shown to participate in the coupling of LTBR to NFkappaB. Here, we report that TRAF3 functions as a negative regulator of LTBR signaling via both canonical and non-canonical NFkappaB pathways by two distinct mechanisms. Analysis of NFkappaB signaling in cell lines with functionally intact NFkappaB pathway but lacking LTBR-mediated induction of NFkappaB target genes revealed an inverse association of cellular TRAF3 levels with LTBR-specific defect in canonical NFkappaB activation. Increased expression of TRAF3 correlated with its increased recruitment to LTBR-induced signaling complexes, decreased recruitment of TRAF2, and attenuated phosphorylation of IkappaB alpha and RelA. In contrast, activation of NFkappaB by TNF did not depend on TRAF3 levels. siRNA-mediated depletion of TRAF3 promoted recruitment of TRAF2 and IKK1 to activated LTBR, enabling LTBR-inducible canonical NFkappaB signaling and NFkappaB target gene expression. TRAF3 knock-down also increased mRNA and protein expression of several non-canonical NFkappaB components, including NFkappaB2/p100, RelB, and NIK, accompanied by processing of NFkappaB2/p100 into p52. These effects of TRAF3 depletion did not require LTBR signaling and were consistent with autonomous activation of the non-canonical NFkappaB pathway. Our data illustrate the function of TRAF3 as a dual-mode repressor of LTBR signaling that controls activation of canonical NFkappaB, and de-repression of the intrinsic activity of non-canonical NFkappaB. Modulation of cellular TRAF3 levels may thus contribute to regulation of NFkappaB-dependent gene expression by LTBR by affecting the balance of LTBR-dependent activation of canonical and non-canonical NFkappaB pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20185819      PMCID: PMC2857099          DOI: 10.1074/jbc.M109.076091

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

Review 1.  The TNF and TNF receptor superfamilies: integrating mammalian biology.

Authors:  R M Locksley; N Killeen; M J Lenardo
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  Signaling to NF-kappaB.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2004-09-15       Impact factor: 11.361

3.  NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway.

Authors:  S C Sun; P A Ganchi; D W Ballard; W C Greene
Journal:  Science       Date:  1993-03-26       Impact factor: 47.728

4.  Dominant negative mutants of TRAF3 reveal an important role for the coiled coil domains in cell death signaling by the lymphotoxin-beta receptor.

Authors:  W R Force; T C Cheung; C F Ware
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

5.  Requirement for NF-kappaB in osteoclast and B-cell development.

Authors:  G Franzoso; L Carlson; L Xing; L Poljak; E W Shores; K D Brown; A Leonardi; T Tran; B F Boyce; U Siebenlist
Journal:  Genes Dev       Date:  1997-12-15       Impact factor: 11.361

6.  Oscillations in NF-kappaB signaling control the dynamics of gene expression.

Authors:  D E Nelson; A E C Ihekwaba; M Elliott; J R Johnson; C A Gibney; B E Foreman; G Nelson; V See; C A Horton; D G Spiller; S W Edwards; H P McDowell; J F Unitt; E Sullivan; R Grimley; N Benson; D Broomhead; D B Kell; M R H White
Journal:  Science       Date:  2004-10-22       Impact factor: 47.728

7.  Lymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappaB.

Authors:  T L VanArsdale; S L VanArsdale; W R Force; B N Walter; G Mosialos; E Kieff; J C Reed; C F Ware
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

8.  Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation.

Authors:  Gongxian Liao; Minying Zhang; Edward W Harhaj; Shao-Cong Sun
Journal:  J Biol Chem       Date:  2004-04-14       Impact factor: 5.157

Review 9.  Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology.

Authors:  Sören Beinke; Steven C Ley
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

10.  Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines.

Authors:  J L Browning; K Miatkowski; I Sizing; D Griffiths; M Zafari; C D Benjamin; W Meier; F Mackay
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  37 in total

1.  NF-κB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression.

Authors:  Feiyan Liu; Kankana Bardhan; Dafeng Yang; Muthusamy Thangaraju; Vadivel Ganapathy; Jennifer L Waller; Georgia B Liles; Jeffrey R Lee; Kebin Liu
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  Nuclear β-adrenergic receptors modulate gene expression in adult rat heart.

Authors:  George Vaniotis; Danny Del Duca; Phan Trieu; Charles V Rohlicek; Terence E Hébert; Bruce G Allen
Journal:  Cell Signal       Date:  2010-08-21       Impact factor: 4.315

Review 3.  Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.

Authors:  Joanne M Hildebrand; Zuoan Yi; Claire M Buchta; Jayakumar Poovassery; Laura L Stunz; Gail A Bishop
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

4.  Herpesvirus entry mediator (HVEM) attenuates signals mediated by the lymphotoxin β receptor (LTβR) in human cells stimulated by the shared ligand LIGHT.

Authors:  John Bechill; William J Muller
Journal:  Mol Immunol       Date:  2014-06-28       Impact factor: 4.407

5.  Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity.

Authors:  Zheng Chen; Hong Shen; Chengxin Sun; Lei Yin; Fei Tang; Pan Zheng; Yang Liu; Robert Brink; Liangyou Rui
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-01-27       Impact factor: 4.310

Review 6.  NF-κB inducing kinase: a key regulator in the immune system and in cancer.

Authors:  Yee Mon Thu; Ann Richmond
Journal:  Cytokine Growth Factor Rev       Date:  2010-08-03       Impact factor: 7.638

7.  Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation.

Authors:  Yoon-Jae Song; Myung-Soo Kang
Journal:  Virus Genes       Date:  2010-06-29       Impact factor: 2.332

8.  Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation.

Authors:  Yan Xiu; Hao Xu; Chen Zhao; Jinbo Li; Yoshikazu Morita; Zhenqiang Yao; Lianping Xing; Brendan F Boyce
Journal:  J Clin Invest       Date:  2013-12-09       Impact factor: 14.808

9.  Cutting Edge: The RNA-Binding Protein Ewing Sarcoma Is a Novel Modulator of Lymphotoxin β Receptor Signaling.

Authors:  Richard Virgen-Slane; Ricardo G Correa; Parham Ramezani-Rad; Seth Steen-Fuentes; Thiago Detanico; Michael J DiCandido; Jun Li; Carl F Ware
Journal:  J Immunol       Date:  2020-01-22       Impact factor: 5.422

10.  Nuclear factor-κB-inducing kinase (NIK) contains an amino-terminal inhibitor of apoptosis (IAP)-binding motif (IBM) that potentiates NIK degradation by cellular IAP1 (c-IAP1).

Authors:  Sunhee Lee; Madhavi Challa-Malladi; Shawn B Bratton; Casey W Wright
Journal:  J Biol Chem       Date:  2014-09-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.